Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the cell viability assays market size evolved in recent years?

The cell viability assays market has seen rapid growth in recent years. It is expected to grow from $1.56 billion in 2024 to $1.73 billion in 2025, at a compound annual growth rate (CAGR) of 10.8%. This growth is attributed to increased investment in cancer research, rising pharmaceutical R&D expenditure, growth in the biotechnology sector, advancements in cell culture techniques, and the increasing demand for stem cell research and toxicity testing.

What are the predictions for the cell viability assays market size in the coming years?

The cell viability assays market is expected to grow rapidly, reaching $2.58 billion by 2029 at a CAGR of 10.5%. This growth is driven by factors such as the increasing demand for personalized medicine, greater government funding for cell-based research, and advances in stem cell research. Other contributing factors include the rising availability of automated cell viability analyzers, a growing focus on precision medicine, the development of organ-on-a-chip technologies, and rising demand for regenerative medicine. Key trends include the adoption of high-throughput screening methods, AI and machine learning algorithms, real-time monitoring systems, and eco-friendly reagents.

Get your cell viability assays market report here!

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

What key factors are fueling the growth of the cell viability assays market?

The rising use of cell-based therapeutics is expected to drive the growth of the cell viability assay market. These treatments use living cells to repair tissue, treat diseases, and restore normal function, supported by advances in biotechnology, regenerative medicine investment, and improved cell engineering. Cell viability assays are essential for ensuring the health and safety of therapeutic cells, optimizing treatment efficacy and quality control. For instance, in Q1 2023, the American Society of Gene & Cell Therapy reported 38 trials for non-genetically modified cell therapies, a rise from 31 in Q4 2022. Thus, cell-based therapeutics are propelling the growth of the cell viability assay market.

How is the global cell viability assays market divided into key segments?

The cell viability assays market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates

2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

Who are the key firms paving the way for growth in the cell viability assays market?

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Which trends are expected to transform the cell viability assays market?

Companies in the cell viability assays market are focusing on innovative cell screening technologies to improve the accuracy and speed of drug discovery. These technologies enable high-throughput, precise, and rapid analysis of cell health, improving experimental conditions and therapeutic strategies. For example, in May 2024, Germany-based Arralyze introduced CellShepherd, a platform for single-cell analysis. The platform uses nanowell glass arrays for real-time monitoring, providing precise cell dispensing and imaging while using AI for accurate cell counting and tracking.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16014

What regions are contributing significantly to the growth of the cell viability assays market?

North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cellular Immunotherapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Stem Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: